ClearPoint Neuro (CLPT) Earnings Outlook for Investors
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,404 articlesClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
BlackRock's Larry Fink presents two stark paths for oil and markets tied to the Iran conflict, challenging households...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Babcock Wilcox stock surged after a mixed Q1 report that featured a revenue beat but a larger-than-expected earnings ...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
A newly clarified rule lets unused 529 college-savings money roll into a Roth IRA, potentially producing substantial,...
Grocery Outlet GO's Q4 2025 earnings transcript sheds light on margin discipline, expansion plans, and the path to 20...
In a shifting rate environment, investors weigh after-tax returns. Some Schwab analysts argue that municipal bonds be...
Gaia’s Q1 2026 results reveal how the company is monetizing its growing audience and investing for long-term growth. ...
A new income model uses a $560,000 portfolio built from covered-call ETFs, preferred shares, and BDCS to generate abo...
Two Nasdaq-100 trackers move in lockstep on performance, but their legal wrappers drive costs and tax implications. H...
When wholesale prices rise, most consumer staples stocks feel the pinch. Coca-Cola, however, has shown resilience. Th...